# A Clinical Trial of CSL's 2010/2011 Formulation of Enzira® in a Healthy Adult Population

> **NCT01113580** · PHASE4 · COMPLETED · sponsor: **Seqirus** · enrollment: 120 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** CSL's 2010/2011 Formulation of Enzira® Vaccine

## Key facts

- **NCT ID:** NCT01113580
- **Lead sponsor:** Seqirus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01113580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01113580, "A Clinical Trial of CSL's 2010/2011 Formulation of Enzira® in a Healthy Adult Population". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01113580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*